Prop 38: Immunology Research Bond

Immunotherapy is individualized treatment designed to harness a patients’ immune system to fight disease. Vaccines are considered part of immunology, but it also includes more recent innovations, like new treatments for cancer and heart disease.   Prop 38 would allow the state to borrow $8.4 billion to fund immunology and immunotherapy research, with one specific institution in mind — UCLA. Additional Resources: Read the transcript for this episode Catch up on all of Prop Fest 2026 Your support makes KQED podcasts possible. You can show your love by going to https://kqed.org/donate/podcasts This story was reported by April Dembosky. Prop Fest is a collaboration between Bay Curious and The Bay. It’s made by Olivia Allen-Price, Katrina Schwartz, Christopher Beale, Anna Casalme, Ericka Cruz Guevarra, Alan Montecillo, Gabriela Glueck and Pauline Bartolone. Additional support from Jen Chien, Katie Sprenger, Maha Sanad, Ethan Toven-Lindsey and everyone on Team KQED. Learn more about your ad choices. Visit megaphone.fm/adchoices